TY  - GEN
AU  - Nali,Luiz Henrique da Silva
AU  - Moraes,Lenira
AU  - Fink,Maria Cristina Domingues
AU  - Callegaro,Dagoberto
AU  - Romano,Camila Malta
AU  - Oliveira,Augusto Cesar Penalva de
TI  - Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients
SN  - 1678-4227
PY  - 2015///0407
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - DNA, Viral
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - JC Virus
KW  - genetics
KW  - Leukoencephalopathy, Progressive Multifocal
KW  - immunology
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Natalizumab
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - Viral Load
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1590/0004-282X20140142
ER  -